TOPIC: A Drug for Duchenne Muscular Dystrophy: FDA's Controversial Approval
SPEAKER: Erica Jonlin
SPEAKER BIOGRAPHY: Erica Jonlin is the regulatory manager for clinical research activities conducted at the University of Washington Institute for Stem Cell and Regenerative Medicine. Her responsibilities include human subjects protection, clinical protocol design, and coordinating and managing the regulatory submission and review processes for clinical research involving products developed from pluripotent stem cells. Dr. Jonlin is also the IRB consultant for the UW Dept. of Pathology, specializing in biospecimens research. She regularly lectures on Good Clinical Practice guidelines, and for thirteen years taught for UW’s Certificate in Clinical Trials program. Dr. Jonlin’s previous experience includes serving as a human subjects review administrator for one of the University of Washington's Institutional Review Boards. Dr. Jonlin was the recipient of an AAAS Science and Diplomacy Fellowship in Washington, D.C., after earning her Ph.D. in Biochemistry at the University of California, Los Angeles.
WHO: Clinical, regulatory, quality, manufacturing and legal
This meeting includes:
- Coffee and tea
Attendance at this meeting may be applied as 1.5 points towards RAC re-certification